Landing
Academy of Managed Care Pharmacy (AMCP) 2022
Real-World Ravulizumab Dosing Patterns Among Patients With Paroxysmal Nocturnal Hemoglobinuria In A US Population
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.